Liver steatosis ups new-onset diabetes after transplantation

August 16, 2016

(HealthDay)—For liver transplant recipients, donor liver steatosis is associated with increased incidence of new-onset diabetes after transplantation (NODAT), according to a study published online Aug. 10 in the Journal of Diabetes Investigation.

Mengjuan Xue, from Fudan University in Shanghai, and colleagues conducted a retrospective analysis of 763 liver transplant recipients to examine whether steatosis increases the incidence of NODAT. They examined the cumulative incidence of NODAT at one, three, five, and 10 years after transplantation.

The researchers found that 40.5 percent of the donors had liver steatosis. The incidence of NODAT in the steatotic donor liver group was 42.1 percent at the end of follow-up, which was higher than in the non-steatotic donor liver group (P = 0.001). At one, three, five, and 10 years, the cumulative incidence of NODAT among all patients was 33, 43, 50, and 56 percent, respectively; at all time points the cumulative incidences of NODAT were higher in the steatotic donor liver group than the non-steatotic donor liver group (P = 0.003). Among recipients, donor liver steatosis was an for NODAT after adjustment for other potential risk factors (hazard ratio, 1.774).

"Donor liver steatosis increases NODAT incidence among liver ," the authors write.

Explore further: Fatty liver disease is common

More information: Abstract
Full Text

Related Stories

Fatty liver disease is common

April 11, 2016
Researchers have characterized the prevalence and risk factors of fatty liver disease in patients who undergo liver transplantation. The findings, which are published in Liver Transplantation, a journal of the American Association ...

Steatosis in more than half of liver transplant recipients

April 8, 2016
(HealthDay)—Steatosis affects more than half of liver transplant (LT) recipients, although it is not associated with worse patient survival, according to a study published online April 5 in Liver Transplantation.

Brazil faces major challenges in liver transplantation

August 1, 2016
A recent analysis indicates that more than 1700 liver transplantations are performed annually in Brazil. While Brazil performs more liver transplant surgeries than anywhere else in Latin America and is third worldwide in ...

Steroid avoidance may not help reduce posttransplant diabetes

June 26, 2015
(HealthDay)—For kidney transplant recipients, steroid avoidance has limited impact for reducing new-onset diabetes after transplantation (NODAT), according to a study published in the July issue of the American Journal ...

Long-term benefits to the liver-kidney transplant

April 15, 2016
A new study from physicians at Mayo Clinic in Rochester, found there may be long-term benefits to simultaneous liver-kidney transplantation versus kidney transplantation alone. The study, "Decreased Chronic Cellular and Antibody-Mediated ...

Study identifies characteristics of patients likely to have a potential living liver donor

June 24, 2015
New research published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that younger patients, those who are married, ...

Recommended for you

Team provides insight into glucagon's role in diabetic heart disease

February 21, 2018
A UT Southwestern study reveals the hormone glucagon's importance to the development of insulin resistance and cardiac dysfunction during Type 2 diabetes, presenting opportunities to develop new therapies for diabetic diseases ...

Physical exercise reduces risk of developing diabetes: study

February 20, 2018
Exercising more reduces the risk of diabetes and could see seven million fewer diabetic patients across mainland China, Hong Kong and Taiwan, according to new research.

Researchers discover link between gut and type 1 diabetes

February 19, 2018
Scientists have found that targeting micro-organisms in the gut, known as microbiota, could have the potential to help prevent type 1 diabetes.

Researchers find existing drug effective at preventing onset of type 1 diabetes

February 15, 2018
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz ...

Chemist designs diabetic treatment minus harmful side effects

February 9, 2018
A chemist in the College of Arts and Sciences (A&S) has figured out how to control glucose levels in the bloodstream without the usual side effects of nausea, vomiting or malaise.

Peptide improves glucose and insulin sensitivity, lowers weight in mice

February 8, 2018
Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.